Preview

User

Not a user? Register with this site Forgot your password?

Problems of Endocrinology

Advanced search

Metabolic and hemostatic characteristics of patients with type 2 diabetes mellitus differing in the severity of angiopathy

https://doi.org/10.14341/probl201056215-19

Abstract

The objective of the present study was to identify risk factors of developing vascular disorders in patients at different stages of type 2 diabetes mellitus (DM2) by comprehensive analysis of metabolic parameters, hemograms, thrombocytic and plasma hemostasis. The study involved 75 patients (22 men and 53 women of mean age 57,3±9,7 years) having angiopathies of different severity. The data obtained confirmed the presence of risk factors of vascular pathology in different phases of DM2. All the examined patients including those without angiopathies in the early period of diabetes showed triglyceridemia, cholesterolemia, enhanced platelet aggregation activity, and shortened activated partial thromboplastin time. Patients with diabetic nephropathy at the stage of microalbuminuria and with non-proliferative retinopathy were distinct from the remaining ones in that they had significantly higher blood alpha-2 globulin and fibrinogen levels. Diabetic patients with micro- and macrovascular problems were characterized by marked dysproteinemia and abnormal platelet disaggregation.

References

1. Ryden L., Co-Chaiperson, Standl E. et al. Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. Eur Heart J 2007; 28: 88-136.

2. Ballard D.J., Humphrey L.L., Melton J. et al. Epidemiology of persistent proteinuria in type II diabetes. Diabetes 1988; 37: 405.

3. Harris M.I. Undiagnosed NIDDM: Public health issues. Diabetes Care 1993; 16: 642.

4. Шевченко О.П., Долгов В.В. Олиференко Г.А. Электрофорез в клинической лаборатории. М: Реафарм 2006; 160.

5. Halushka P.V., Rogers R.C., Loadholt C.B., Colwell J.A. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 1981; 97: 87-96.

6. Sobol A.B., Watala C. The role of platelets in diabetes-related vascular complications. Diabetes Res Clin Pract 2000; 50: 1-16.

7. Абесадзе А.И., Мозидзе М.А., Квернадзе М.Г. и др. Гормональный механизм регуляции тромбопоэза. Вестн АМН СССР 1990; 9: 47-52.

8. Negrev N. The effect of insulin in thrombocytopoiesis and thrombocytopoietin biosynthesis in rats. Exp Med Morfol 1990; 29: 24: 24-27.

9. Халфен Э.Ш., Белоусова С.С., Шварц И.П., Иконникова Е.И. Влияние липопротеидов различных классов на агрегацию тромбоцитов. Кардиология 1984; 2: 32-35.

10. Kozek E., Katra B., Malecri M. Visceral obesity and haemostatic profile in patients with type 2 diabetes: the effect of gender and metabolic compensation. Rev Diabet Stud 2004; 1: 3: 122-128.

11. Сorrado E., Rizzo M., Muratori I. Assotiation of elevated fibrinogen and CRP levels with carotid lesions in patients with newly diagnosed hypertension on type 2 diabetes. Arch Med Res 2006; 37: 8. 1004-1009.

12. Dunn E., Ariens R., Grant P. The influence of type 2 diabetes on fibrin structure and function. Diabetologia 2005; 48: 1198-1206.

13. Umpaichitra V., Hussan M.M., Castells S. PAI-1 and t-PA in minority adolesgents with type 2 diabetes and obesity. Pediatr Res 2006; 59: 5: 746-750.

14. Шитикова А.С. Тромбоцитарный гемостаз. Ст-Петербург: Изд-во СПбГМУ 2000; 141.


Review

For citations:

Petrik G.G., Pavlishchuk S.A. Metabolic and hemostatic characteristics of patients with type 2 diabetes mellitus differing in the severity of angiopathy. Problems of Endocrinology. 2010;56(2):15-19. https://doi.org/10.14341/probl201056215-19

Views: 331


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)

11, Dm. Ul’yanova str., Moscow, Russian Federation, 117292

Processing of personal data
supported by NEICON (Elpub lab)